Nuvation Bio (NUVB) Jumps 16% Amid Financial Results For The Second Quarter

The stock was fluctuating at $8.00 with small volatility from August 18 till August 20. Then, it sharply jumped to $9.02 on August 23 and it is still trading at that level. The total volume of the company is 534,847 shares while the average volume consists of 761,668 shares. The market capitalization is $1.999 billion.

Just recently, Nuvation Bio reported the financial results for the second quarter. Research and development expenses are $14.0 million, compared to $7.3 million in the last year. General and administrative expenses are $6.4 million which is higher compared to $1.7 million in the previous year. A net loss of $19.3 million, or $0.09 per share. 

David Hung, CEO of the company said that the second quarter of 2021 stamped different accomplishments for Nuvation Bio. With the arrangement of David C. Hanley, Ph.D., as Chief Specialized Operations Officer, they are progressing their supply chain, item improvement, and fabricating endeavors.

Agneta Johansen

Agneta is still enjoying her trips to Asia and Africa while she works at Own Snap as an author and reporter. Very soon she will settle somewhere in Europe and run her startup enterprise.